People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nekcom Inc. | — | Other | Series A | $15.0M | $59.5M | 2024 |
| Weikang Bio-Technology Group Co., Inc. | — | Pharmaceuticals | Series A | $10.0M | $154.9M | 2010 |
Yan Huang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yan Huang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wei Wang | 1 | 7 |
| Xiaoyun Dong | 1 | 1 |
| Jixuan Fang | 1 | 1 |
| Ryan You | 1 | 1 |
| Dongning Li | 1 | 1 |
| Xiangyu Luo | 1 | 1 |
| Guangzhi Ma | 1 | 1 |
| Yin Wang | 1 | 1 |
| Allen Zhang | 1 | 1 |
| Baolin Sun | 1 | 1 |
| Yilun Jin | 1 | 1 |
| Yvonne Zhang | 1 | 1 |
| Guangxin Wang | 1 | 1 |
| Yuanyuan Jing | 1 | 1 |
| Weili Wang | 1 | 1 |
| Yanhua Liu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.